Navigation Links
Curemark CEO Presents Autism Findings at Prestigious Neurobiology Conference at Oxford
Date:9/17/2008

Curemark, LLC announced today that Founder and CEO Dr. Joan Fallon has presented Curemark's most recent findings on autism at the Gordon Conference on Neurobiology and Brain Disorders which took place August 24-29 at Magdalene College in Oxford.

Rye, NY (PRWEB) September 17, 2008 -- www.cure-mark.com [Curemark, LLC] announced today that Founder and CEO Dr. Joan Fallon has presented Curemark's most recent findings on autism at the Gordon Conference on Neurobiology and Brain Disorders which took place August 24-29 at Magdalene College in Oxford. This 5-day conference brings together some of the greatest research minds from around the world in the field of neurobiology both from academia and industry.

Dr. Fallon's paper, entitled, "The Role of a Dearth of Amino Acids in the Pathophysiology of Autism" details the groundbreaking discoveries regarding autism and its possible origins. This research is the focus of Curemark's plans for entering into clinical trials.

"It was an incredible honor to be among the most elite scientists in the world looking at the genetics of autism, Alzheimer's, Parkinson's disease and other neurodegenerative conditions." Commented Dr.Fallon, The Gordon Conferences are one of pre-eminent meetings in the world, and I am grateful that Curemark was able to be represented."

Present at the meeting were scientists from MIT, Harvard, Johns Hopkins, Oxford, Cambridge and other prestigious universities from around the world.

Curemark is a drug development company focused on the treatment of neurological and other diseases by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company's initial products are based upon breakthrough observations by its founder, Dr. Joan Fallon, which revealed a lack of key enzymes in children with autism. The company is currently preparing for Clinical Trials. To learn more about Curemark's innovative science, visit www.cure-mark.com.

For more information, contact:
Alissa Minio
info @ cure-mark.com
(914) 925-3450

# # #

Read the full story at http://www.prweb.com/releases/Curemark/Neurobiology_Conference/prweb1338504.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. AMA Foundation Presents the Arthur N. Wilson, MD Scholarship to Promising Medical Student From Southeast Alaska
2. USA-ONE Interactive Presents a Free Webinar Series Introducing Docuvation – An Online Document Management Solution
3. AMA Foundation Presents $10,000 Scholarships to Promising Medical Students
4. Neurotherapeutics presents special issue on new treatments for Alzheimers disease
5. Vertos Medical Inc. Presents Clinical Data of its MILD™ Procedure at the 5th Annual Innovative Techniques in Spine Surgery Conference in Los Cabos, Mexico
6. Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics Congress in Budapest, Hungary
7. ExonHit Presents Therapeutic and Diagnostic Programs for Alzheimers at ICAD 2008
8. OptiNose presents data on highly effective migraine treatment
9. International Association for Dental Research presents awards and fellowships
10. MIKE AND IKE(R) Lemonade Blends(TM) Presents $100,000 to Alexs Lemonade Stand Foundation
11. Journal STEM CELLS Presents 3rd Annual Young Investigator Award at International Stem Cell Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... , June 23, 2016 Revolutionary ... Oticon , industry leaders in advanced audiology ... of Oticon Opn ™, the world,s first internet ... possibilities for IoT devices.      (Photo: ... introduces a number of ,world firsts,: , ...
Breaking Medicine Technology: